Skip to main content
. Author manuscript; available in PMC: 2010 May 15.
Published in final edited form as: Clin Cancer Res. 2009 Oct 27;15(22):6993–7002. doi: 10.1158/1078-0432.CCR-09-0991

Table I. Disease specific survival analysis of the NKG2D ligands MIC, RAET1E, RAET1G, ULBP1, ULBP2 and ULBP3.

Data presented for each ligand expression case. Combinations of ligand expression are only presented in cases where statistical significance was found.

Variable Mean DSS
(months)
Survival range
(months)
Log-rank
p-value
Cox regression
p-value
HR Lower
CI
Upper
CI
MICA
expression
High 68 62-74 0.035 0.04 0.76 0.59 0.99
Low 56 47-65

ULBP1
expression
High 67 61-73 0.055 0.045 0.81 0.64 1.05
Low 58 50-66

ULBP2
expression
High 60 54-66 0.466 0.39 1.13
Low 67 60-74

ULBP3
expression
High 66 58-74 0.53 0.492 0.91
Low 63 57-70

RAET1E
expression
High 65 58-72 0.642 0.299 0.84
Low 64 57-71

RAET1G
expression
High 74 65-83 0.01 0.03 0.74 0.551 1
Low 62 56-67

MICA and
ULBP1
Both high 67 60-73 0.018 0.006 0.83 0.7 0.97
Single high 66 57-74
Both low 50 38-62

MICA and
RAET1E
Both high 68 62-74 0.02 0.014 0.86 0.77 0.97
Single high 61 51-72
Both low 44 30-59

MICA and
RAET1G
Both high 77 68-87 0.003 0.005 0.84 0.74 0.95
Single high 64 56-71
Both low 54 44-64

ULBP1 and
RAET1E
Both high 68 59-72 0.041 0.039 0.81
Single high 62 55-70
Both low 45 27-63

ULBP1 and
RAET1G
Both high 73 63-84 0.027 0.032 0.83
Single high 65 58-72
Both low 57 48-65

RAET1E and
RAET1G
Both high 76 67-86 0.004 0.002 0.84 0.77 0.99
Single low/
Both low
61 55-67